Edwards Lifesciences (EW) PT Raised to $110 at Jefferies

April 21, 2021 8:09 AM EDT
Get Alerts EW Hot Sheet
Price: $90.65 -1.65%

Rating Summary:
    21 Buy, 15 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 16 | New: 44
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Jefferies analyst Raj Denhoy raised the price target on Edwards Lifesciences (NYSE: EW) to $110.00 (from $105.00) while maintaining a Buy rating.

The analyst commented, "EW posted $60mn/$0.07 beat with US TAVR flat offset by a rebound OUS to low DDs(HSD in 4Q) on strong uptake in Japan, which offset a staggered EU performance. The late March rebound is extending into early April, keeping the outlook for +15-20% global TAVR growth unchanged. With TAVR trends normalizing and several pivotal TMTT data readouts slated for ACC and EuroPCR later this year (CLASP, TRISCEND), the 2021 set-up points to further upside. PT to $110."



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co